Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Chu

Showing results (1201-1210 of 1,215) with videos related to

Pageof 122
Sort By:
The Lancet. Infectious Diseases|September 25, 2023
Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysisRobert J Commons, Megha Rajasekhar, Peta Edler, et al.
Plos Medicine|October 5, 2019
The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysisRobert J Commons, Julie A Simpson, Kamala Thriemer, et al.
Nature|June 15, 2018
Author Correction: Discovery of stimulation-responsive immune enhancers with CRISPR activationDimitre R Simeonov, Benjamin G Gowen, Mandy Boontanrart, et al.
Nature|August 31, 2017
Discovery of stimulation-responsive immune enhancers with CRISPR activationDimitre R Simeonov, Benjamin G Gowen, Mandy Boontanrart, et al.
Malaria Journal|October 11, 2023
Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysisParinaz Mehdipour, Megha Rajasekhar, Saber Dini, et al.
The Lancet. Child & Adolescent Health|September 27, 2024
Primaquine for uncomplicated Plasmodium vivax malaria in children younger than 15 years: a systematic review and individual patient data meta-analysisRobert J Commons, Megha Rajasekhar, Elizabeth N Allen, et al.
Malaria Journal|November 14, 2025
Automated reporting of primaquine dose efficacy, tolerability and safety for Plasmodium vivax malaria using a systematic review and individual patient data meta-analysisPeta Edler, Megha Rajasekhar, David J Price, et al.
BMC Medicine|August 2, 2019
The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysisRobert J Commons, Julie A Simpson, Kamala Thriemer, et al.
The Lancet. Infectious Diseases|July 24, 2018
The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysisRobert J Commons, Julie A Simpson, Kamala Thriemer, et al.
Communications Biology|December 23, 2022
A molecular barcode and web-based data analysis tool to identify imported Plasmodium vivax malariaHidayat Trimarsanto, Roberto Amato, Richard D Pearson, et al.
Pageof 122

Showing results (1201-1210 of 1,215) with videos related to

Sort By:
Pageof 122
The Lancet. Infectious Diseases|September 25, 2023
Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysisRobert J Commons, Megha Rajasekhar, Peta Edler, et al.
Plos Medicine|October 5, 2019
The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysisRobert J Commons, Julie A Simpson, Kamala Thriemer, et al.
Nature|June 15, 2018
Author Correction: Discovery of stimulation-responsive immune enhancers with CRISPR activationDimitre R Simeonov, Benjamin G Gowen, Mandy Boontanrart, et al.
Nature|August 31, 2017
Discovery of stimulation-responsive immune enhancers with CRISPR activationDimitre R Simeonov, Benjamin G Gowen, Mandy Boontanrart, et al.
Malaria Journal|October 11, 2023
Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysisParinaz Mehdipour, Megha Rajasekhar, Saber Dini, et al.
The Lancet. Child & Adolescent Health|September 27, 2024
Primaquine for uncomplicated Plasmodium vivax malaria in children younger than 15 years: a systematic review and individual patient data meta-analysisRobert J Commons, Megha Rajasekhar, Elizabeth N Allen, et al.
Malaria Journal|November 14, 2025
Automated reporting of primaquine dose efficacy, tolerability and safety for Plasmodium vivax malaria using a systematic review and individual patient data meta-analysisPeta Edler, Megha Rajasekhar, David J Price, et al.
BMC Medicine|August 2, 2019
The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysisRobert J Commons, Julie A Simpson, Kamala Thriemer, et al.
The Lancet. Infectious Diseases|July 24, 2018
The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysisRobert J Commons, Julie A Simpson, Kamala Thriemer, et al.
Communications Biology|December 23, 2022
A molecular barcode and web-based data analysis tool to identify imported Plasmodium vivax malariaHidayat Trimarsanto, Roberto Amato, Richard D Pearson, et al.
Pageof 122